Tela Bio Stock Performance
| TELA Stock | USD 2.99 0.15 4.78% |
On a scale of 0 to 100, Tela Bio holds a performance score of 4. The entity has a beta of 0.37, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Tela Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding Tela Bio is expected to be smaller as well. Please check Tela Bio's semi variance, rate of daily change, and the relationship between the value at risk and kurtosis , to make a quick decision on whether Tela Bio's existing price patterns will revert.
Risk-Adjusted Performance
4 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Tela Bio are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain essential indicators, Tela Bio sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (4.78) | Five Day Return (1.32) | Year To Date Return (54.83) | Ten Year Return (77.60) | All Time Return (77.60) |
1 | TELA Bio, Inc. Shares Acquired by Paradigm Capital Management Inc. NY - MarketBeat | 09/24/2024 |
2 | Acquisition by Peter Murphy of 19300 shares of Tela Bio at 7.07 subject to Rule 16b-3 | 09/25/2024 |
3 | Acquisition by Blizard Jeffrey of 6375 shares of Tela Bio subject to Rule 16b-3 | 09/27/2024 |
4 | TELA Bio Enters Underwriting Agreement for Public Offering | 10/24/2024 |
5 | Insiders Of TELA Bio Reap Rewards After Their Investment Jumps Another US69k | 10/28/2024 |
6 | What To Expect From TELA Bio Inc Q3 2024 Earnings | 11/06/2024 |
7 | TELA Bio, Inc. Reports Q3 Loss, Lags Revenue Estimates | 11/07/2024 |
8 | TELA Bio Inc Q3 2024 Earnings Call Highlights Strong Revenue Growth and Strategic ... | 11/08/2024 |
9 | Piper Sandler Cuts TELA Bio Price Target to 5.00 | 11/11/2024 |
10 | TELA Bio Set to Unveil Innovations at Piper Sandlers Premier Healthcare Conference - MyChesCo | 11/21/2024 |
| Begin Period Cash Flow | 42 M |
Tela |
Tela Bio Relative Risk vs. Return Landscape
If you would invest 272.00 in Tela Bio on September 4, 2024 and sell it today you would earn a total of 27.00 from holding Tela Bio or generate 9.93% return on investment over 90 days. Tela Bio is currently generating 0.2061% in daily expected returns and assumes 3.4598% risk (volatility on return distribution) over the 90 days horizon. In different words, 30% of stocks are less volatile than Tela, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Tela Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tela Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Tela Bio, and traders can use it to determine the average amount a Tela Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0596
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TELA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.46 actual daily | 30 70% of assets are more volatile |
Expected Return
| 0.21 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Tela Bio is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tela Bio by adding it to a well-diversified portfolio.
Tela Bio Fundamentals Growth
Tela Stock prices reflect investors' perceptions of the future prospects and financial health of Tela Bio, and Tela Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Tela Stock performance.
| Return On Equity | -3.42 | ||||
| Return On Asset | -0.41 | ||||
| Profit Margin | (0.60) % | ||||
| Operating Margin | (0.49) % | ||||
| Current Valuation | 142 M | ||||
| Shares Outstanding | 39.39 M | ||||
| Price To Book | 22.99 X | ||||
| Price To Sales | 1.72 X | ||||
| Revenue | 58.45 M | ||||
| Gross Profit | 27.85 M | ||||
| EBITDA | (40.63 M) | ||||
| Net Income | (46.66 M) | ||||
| Cash And Equivalents | 27.73 M | ||||
| Cash Per Share | 1.90 X | ||||
| Total Debt | 41.08 M | ||||
| Debt To Equity | 3.33 % | ||||
| Current Ratio | 3.83 X | ||||
| Book Value Per Share | (0.25) X | ||||
| Cash Flow From Operations | (40.86 M) | ||||
| Earnings Per Share | (1.69) X | ||||
| Market Capitalization | 117.77 M | ||||
| Total Asset | 78.05 M | ||||
| Retained Earnings | (320.89 M) | ||||
| Working Capital | 54.76 M | ||||
About Tela Bio Performance
By analyzing Tela Bio's fundamental ratios, stakeholders can gain valuable insights into Tela Bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Tela Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Tela Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 261.93 | 311.87 | |
| Return On Tangible Assets | (0.61) | (0.65) | |
| Return On Capital Employed | (0.72) | (0.76) | |
| Return On Assets | (0.60) | (0.63) | |
| Return On Equity | (2.47) | (2.60) |
Things to note about Tela Bio performance evaluation
Checking the ongoing alerts about Tela Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Tela Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Tela Bio had very high historical volatility over the last 90 days | |
| Tela Bio has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 58.45 M. Net Loss for the year was (46.66 M) with profit before overhead, payroll, taxes, and interest of 27.85 M. | |
| Tela Bio currently holds about 27.73 M in cash with (40.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.9. | |
| Latest headline from news.google.com: TELA Bio Set to Unveil Innovations at Piper Sandlers Premier Healthcare Conference - MyChesCo |
- Analyzing Tela Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Tela Bio's stock is overvalued or undervalued compared to its peers.
- Examining Tela Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Tela Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Tela Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Tela Bio's stock. These opinions can provide insight into Tela Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Tela Stock analysis
When running Tela Bio's price analysis, check to measure Tela Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tela Bio is operating at the current time. Most of Tela Bio's value examination focuses on studying past and present price action to predict the probability of Tela Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tela Bio's price. Additionally, you may evaluate how the addition of Tela Bio to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |